Atlas Trials

Genius Study Study to Compare Efficacy and Safety of Gefitinib/ Pemetrexed With Pemetrexed Alone as Maintenance Therapy in Patients With Stage IV EGFR Mutation Negative or T790M Single Mutation Who Respond to Pemetrexed/ Platinum as First-line Therapy

Clinical trial NCT01579630 · UNKNOWN

Trial details

NCT number
NCT01579630
Sponsor
Taipei Veterans General Hospital, Taiwan
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
NSCLC
Start date
2011-03-01
Primary completion
2013-06-01
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.